Protagonist Therapeutics shareholders elect directors, approve say-on-pay, ratify auditor

Protagonist Therapeutics, Inc

Harold Selick and Bryan Giraudo elected Class III directors with ~83% and ~79% of votes cast, respectively.
Non-binding advisory vote on executive compensation approved: 50.8M for, 2.9M against, 0.3M abstentions.
Ratification of Ernst & Young as independent auditor for FY 2025 approved: 55.5M for, 74k against, 0.4M abstentions.
No other proposals were submitted; broker non-votes were 1,918,517 for all director and say-on-pay items.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.